UNSPSC 12141752
The global commercial market for Bohrium (Bh) is non-existent, with a Total Addressable Market (TAM) of $0. As a synthetic, highly radioactive element with a half-life measured in seconds, Bohrium is produced only in atom-scale quantities for fundamental scientific research. Consequently, there is no commercial production, supply chain, or pricing mechanism. The primary strategic imperative is not opportunity capture but the de-listing of this and similar non-commercial elements from procurement systems to prevent misallocation of corporate resources.
The commercial market for Bohrium is $0. The element is not traded and has no industrial, manufacturing, or value-added applications. Production is restricted to a handful of government-funded particle accelerator facilities globally, created on an atom-by-atom basis for research purposes only. Projections for commercialisation are non-existent; therefore, the 5-year CAGR is 0%.
The "markets" are not geographic regions of consumption but locations of synthesis capability: 1. Darmstadt, Germany (GSI Helmholtz Centre for Heavy Ion Research) 2. Dubna, Russia (Joint Institute for Nuclear Research - JINR) 3. Berkeley, CA, USA (Lawrence Berkeley National Laboratory - LBNL)
| Year | Global TAM (USD) | CAGR |
|---|---|---|
| 2023 | $0 | 0.0% |
| 2024 (est.) | $0 | 0.0% |
| 2025 (proj.) | $0 | 0.0% |
The concept of a commercial competitive landscape does not apply. The "producers" are state-funded research consortia, not commercial enterprises. They collaborate more often than they compete.
Tier 1 "Leaders" (Research Institutions)
Emerging/Niche Players
Barriers to Entry are, for all practical purposes, infinite. They include the est. >$1B capital cost for a suitable particle accelerator, access to world-leading nuclear physics expertise, and national-level operating budgets.
There is no commercial price for Bohrium. It has never been bought or sold.
The "cost of production" is a theoretical calculation based on the operational expense of a particle accelerator experiment. This includes massive electricity consumption, liquid helium for cooling superconducting magnets, labour costs for PhD-level physicists and technicians, and the cost of the target materials. A single experiment to produce a few atoms of a superheavy element can have an all-in cost of est. $5M - $10M. This cost is borne by national science budgets and cannot be amortised into a per-gram or per-atom price for commercial sale.
The three most significant (but theoretical) cost inputs would be: 1. Accelerator Beam Time: The primary cost driver, representing electricity, maintenance, and personnel. Volatility is linked to institutional budgets and energy prices. 2. Target Material (e.g., ²⁰⁹Bi): While Bismuth is not exceptionally expensive, creating a pure, stable target suitable for bombardment is a high-cost, custom process. 3. Ion Source Material (e.g., ⁵⁴Cr): Requires isotopically enriched material, which is significantly more expensive than the naturally occurring element.
No commercial suppliers exist. The following table lists the research institutions capable of its synthesis.
| Institution / Region | Est. Market Share | Exchange:Ticker | Notable Capability |
|---|---|---|---|
| GSI Helmholtz Centre / Darmstadt, DE | N/A (Non-commercial) | N/A (Gov't Funded) | Original discovery; UNILAC accelerator. |
| JINR / Dubna, RU | N/A (Non-commercial) | N/A (Gov't Funded) | Pioneering work in superheavy elements. |
| LBNL / Berkeley, USA | N/A (Non-commercial) | N/A (Gov't Funded) | 88-Inch Cyclotron; Berkeley Gas-filled Separator. |
| Riken / Wako, JP | N/A (Non-commercial) | N/A (Gov't Funded) | RIKEN Ring Cyclotron; GARIS separator. |
North Carolina has a sophisticated research infrastructure, including the Triangle Universities Nuclear Laboratory (TUNL), a Department of Energy Center of Excellence. However, there is zero commercial demand for Bohrium within the state's industrial base (e.g., biotech, manufacturing, chemicals). Furthermore, there is no local capacity for synthesizing superheavy elements like Bohrium; this capability is restricted to a few national laboratories globally. State tax, labour, and regulatory frameworks are irrelevant to this commodity, as it will never be produced, transported, or used commercially in North Carolina.
This risk assessment is framed from the perspective of attempting to source a non-existent commercial product.
| Risk Category | Grade | Justification |
|---|---|---|
| Supply Risk | High | Supply is physically impossible. The commodity cannot be procured through any commercial channel at any price. |
| Price Volatility | High | The "price" is effectively infinite. There is no market price, making it impossible to budget for or hedge. |
| ESG Scrutiny | Low | No industrial application means no supply chain, emissions, or waste concerns for our organisation. The element's radioactivity is managed within secure lab environments. |
| Geopolitical Risk | Low | Not a strategic material. Production is limited to a few nations that generally collaborate on fundamental science. |
| Technology Obsolescence | Low | As a fundamental element of the periodic table, it cannot become obsolete. The "technology" is the science of its creation, which is constantly advancing. |
Immediately de-list UNSPSC 12141752 (Bohrium) and its associated data from all procurement software, category plans, and spend analytics platforms. This is a non-commercial, non-procurable research element. This action will eliminate resource waste on sourcing an unobtainable material and improve data integrity.
Initiate a data governance audit of the "Elements and gases" family (UNSPSC 12140000) to identify and flag other synthetic, superheavy elements (e.g., Hassium, Meitnerium). This proactive clean-up will focus category management efforts on commercially viable chemicals and prevent similar analytical exercises in the future.